(Q44448110)

3 December 2017

title

Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease (English)

1 reference

3 December 2017

1 reference

Blann AD

1

1 reference

3 December 2017

Constans J

2

1 reference

3 December 2017

Carpentier P

3

1 reference

3 December 2017

Renard M

4

1 reference

3 December 2017

Satger B

5

1 reference

3 December 2017

Guérin V

6

1 reference

3 December 2017

Boisseau MR

7

1 reference

3 December 2017

Neau-Cransac N

8

1 reference

3 December 2017

Conri C

9

1 reference

3 December 2017

language of work or name

1 reference

1 February 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

109

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

203-206

1 reference

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

The aetiopathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Serological markers in progressive systemic sclerosis: clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Hypothesis: is soluble P-selectin a new marker of platelet activation?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Soluble P-Selectin in the Plasma of Patients with Connective Tissue Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Antiendothelial cell antibodies: useful markers of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Effects of desmopressin on circulating P-selectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Soluble P-selectin is released from activated platelets in vivo during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Soluble P-selectin and the risk of future cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900209-3

7 January 2021

10.1016/S0049-3848(03)00209-3

Identifiers

DOI

1 reference

3 December 2017

1 reference